drugset
drugset / Trial / NCT04784000

Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527

NCT04784000 ↗

Phase 1 Completed 20 enrolled Atea Pharmaceuticals, Inc. Hoffmann-La Roche · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will determine the effect of carbamazepine on the PK of AT-527 (RO7496998) in healthy adult subjects.

Timeline

Start
2021-03-01
Primary completion
2021-04-10
Completion
2021-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AT-527 Other / unclassified 550 mg —
Subject AT-527 Other / unclassified 1100 mg —
Subject Carbamazepine Small molecule 300 mg —

Indications

No indication recorded.